India GSK Consumer zooms 20 pct on parent's open offer plan
MUMBAI Nov 26 (Reuters) - Shares in GlaxoSmithKline Consumer Healthcare, the Indian arm of GlaxoSmithKline , surged 20 percent to their maximum daily limit on Monday, following news that its UK-based parent group plans to raise its stake in the unit via an open offer.
GlaxoSmithKline Plc, along with its units, will buy up to 13.39 million shares, or an additional 31.84 percent in GlaxoSmithKline Consumer Healthcare, at 3,900 rupees per share, said HSBC Securities, the manager to the offer, in a statement.
Valued at $2.3 billion, shares in GSK Consumer Healthcare were locked at 3,659.20 rupees, up 20 percent to their maximum daily trading limit, while the Mumbai market was up 0.23 percent by 0347 GMT. (Reporting by Kaustubh Kulkarni and Manoj Dharra; Editing by Jijo Jacob)
- Tweet this
- Share this
- Digg this
- U.S. strikes have slowed Iraq militants but not weakened them - Pentagon
- Modi slams whispering campaign against Rajnath Singh
- Islamic State executes soldiers, takes hostages at Syria base - social media
- India's coal crunch - a chance to revamp, reallocate and revive
- Sensex, Nifty mark record closing high on Euro zone stimulus talk
COAL BLOCK ALLOCATIONS
A Supreme Court ruling this week that India's decades-old method of granting coal mining concessions is illegal could herald much-needed reforms in a sector long dogged by the inability of state-run Coal India to raise output fast enough. Read
Kleiner to invest in messaging startup Snapchat at near-$10 bln valuation - report. Full Article